CD103+ cDCs are pivotal for tumor immunosurveillance: (i) they transport tumor antigens to regional lymph nodes, where they cross-prime T cells9 and (ii) they are key cellular sources of the T cell-attracting chemokines at tumors10. The gene discussed is ITGAE; the disease is neoplasm.